Close Menu
    Facebook X (Twitter) Instagram
    FlickonclickFlickonclick
    Facebook X (Twitter) Instagram
    Contact Us
    • Home
    • Entertainment
    • Photos
    • Lifestyle
    • Wealth
    • News
      • Finance
      • Fitness
      • Technology
    • Biography Corner
    • Trending
    • Advertise with Us
    FlickonclickFlickonclick
    Home » Finance » Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?
    Finance

    Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?

    By FlickonclickJuly 17, 2021
    Facebook Twitter WhatsApp Email

    There’s too much going on in the investment market of India and starting from Zomato opening its IPO, more are following such as Tatva Chintan Pharma, which is quite a reputated brand in its domain.




    They deal majorly in pharma products in verticals such as automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries.

    Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?

    When did Tatva Chinta Pharma IPO started?

    The IPO had open for subscription from 16th July 2021 with ₹225 crores of fresh equity shares by the Tatva Chintan Pharma and ₹275 crores of an offer for sale (OFS) to its allied members.




    Do not forget that the Price brand for the company is ₹1,073 – ₹1,083 and it would turn out to be a good investment if it’s for the long term.

    There are other aspects in support of this being a good investment such as the analysis by some of the top tier stockbroking firms such as Investmentz. Here’s what they have to say.

    “The company earns 30% of revenue from pharmaceutical and agrochemical intermediates and other specialty chemicals, which are export orders shifted from China to India. With its superior product mix, established brand name, forward integration, strong relationships with multinationals, and adding capacities, we believe Tatva Chintan is likely to deliver healthy financial performance,” said a report by stockbroking platform Investmentz.



    Report analysis of Tatva China Pharma IPO

    It is clear from the report and what analysts says that if you’re into long-term investing then it would be a good option otherwise not.

    It is to be kept in mind that the Pharma industry is on an exponential growth pattern with 5-6% of growth observance in the upcoming five years. The industry is currently valued at a total of $800 billion (as measured back in 2019).

    Tatva Chintan Pharma has a strong record with a powerful balance sheet, and factors such as them being the key industry player and having high growth potential help their IPO uprising.

    Also Read- Zomato Announced IPO: Should You Be Subscribing It?




    IPO
    Previous ArticleAndroid Smartphones War: One Plus 09 Pro V/S Samsung Galaxy S21 Plus 5G
    Next Article Mastercard Ban: What’s The Reason Behind It And What Happens Next?
    Flickonclick

      Tanya Goyal and Tanuj Kwatra are the creative minds and co-founders behind this website. Both share a deep passion for writing and storytelling, focusing on crafting SEO-optimized, reader-friendly articles that inform and entertain. Their goal is to make every piece of content valuable—whether it’s about sports, entertainment, lifestyle, or digital trends—while maintaining originality and authenticity in every post.

      Related Posts

      Tata Sons’ IPO Could Be Worth ₹55,000 Crore! How Prepared Are They and What Role Will RBI Play?

      Read More

      LIC IPO to open on May 4 for retail investors: Know how to invest

      Read More

      LIC IPO: Everything you need to know about LIC public offerings

      Read More

      boAt Set to Float IPO Worth Rs 2000 Crore: Things You Should Know As An Investor

      Read More

      Paytm IPO: one of the biggest public offerings today; should you invest money?

      Read More

      Everything You Should Know From Nykaa IPO Launch on October 28

      Read More

      Zomato Announced IPO: Should You Be Subscribing It?

      Read More

      The Indian Railway Finance Corporation(IRFC) IPO set to Open Its Services

      Read More
      Latest Articles

      Ravneet Kaur (Gippy Grewal Wife) Age, Height, Net Worth, Son, Education, Biography

      November 18, 2025

      Top 10 Most Expensive Laptops of 2025

      November 18, 2025

      Top 10 Most Expensive Smartphones of 2025

      November 18, 2025

      Important Update for Indians Traveling to Iran: Visa-Free Entry Suspended for Ordinary Passport Holders

      November 18, 2025

      120 Bahadur: OTT Release Date & Platform

      November 18, 2025

      Tere Ishk Mein Cast Salaries and Budget: Complete Details

      November 17, 2025

      The Running Man OTT Release Date in India: Latest Updates

      November 17, 2025

      Now You See Me 3 OTT Release Date in India: Full Update

      November 17, 2025

      IRB Wins 9270 Crore NHAI Project: Share Market May React Strongly

      November 16, 2025

      No More Regular Passports: India Switches to Secure E-Passports

      November 16, 2025
      About Flickonclick

      Flickonclick brings you the latest updates across entertainment, lifestyle, tech, and more. Stay informed with trending news and stories that matter.

      Facebook X (Twitter) Instagram
      Latest Articles
      • Ravneet Kaur (Gippy Grewal Wife) Age, Height, Net Worth, Son, Education, Biography
      • Top 10 Most Expensive Laptops of 2025
      • Top 10 Most Expensive Smartphones of 2025
      • Important Update for Indians Traveling to Iran: Visa-Free Entry Suspended for Ordinary Passport Holders
      Important Links
      • Privacy Policy
      • Advertise with Us
      • Disclaimer
      • About Us
      • Contact Us
      • Write for Us
      • Home
      © 2025 Flickonclick

      Type above and press Enter to search. Press Esc to cancel.